• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用临床试验数据估算潜在采用者行为干预措施的成本:试验研究者指南。

Using Clinical Trial Data to Estimate the Costs of Behavioral Interventions for Potential Adopters: A Guide for Trialists.

机构信息

Department of Medical Ethics and Health Policy, Perelman School of Medicine, and Center for Health Incentives and Behavioral Economics, University of Pennsylvania, Philadelphia, PA, USA.

The Leonard Davis Institute of Health Economics (LDI), University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Med Decis Making. 2021 Jan;41(1):9-20. doi: 10.1177/0272989X20973160. Epub 2020 Nov 20.

DOI:10.1177/0272989X20973160
PMID:33218296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7772275/
Abstract

Behavioral interventions involving electronic devices, financial incentives, gamification, and specially trained staff to encourage healthy behaviors are becoming increasingly prevalent and important in health innovation and improvement efforts. Although considerations of cost are key to their wider adoption, cost information is lacking because the resources required cannot be costed using standard administrative billing data. Pragmatic clinical trials that test behavioral interventions are potentially the best and often only source of cost information but rarely incorporate costing studies. This article provides a guide for researchers to help them collect and analyze, during the trial and with little additional effort, the information needed to inform potential adopters of the costs of adopting a behavioral intervention. A key challenge in using trial data is the separation of implementation costs, the costs an adopter would incur, from research costs. Based on experience with 3 randomized clinical trials of behavioral interventions, this article explains how to frame the costing problem, including how to think about costs associated with the control group, and describes methods for collecting data on individual costs: specifications for costing a technology platform that supports the specialized functions required, how to set up a time log to collect data on the time staff spend on implementation, and issues in getting data on device, overhead, and financial incentive costs.

摘要

涉及电子设备、经济激励、游戏化和专门培训的员工以鼓励健康行为的行为干预措施在健康创新和改善工作中变得越来越普遍和重要。尽管成本考虑是广泛采用这些措施的关键,但由于无法使用标准行政计费数据对所需资源进行计价,因此缺乏成本信息。检验行为干预措施的实用临床试验可能是成本信息的最佳来源,而且通常也是唯一来源,但很少纳入成本研究。本文为研究人员提供了一个指南,帮助他们在试验期间并只需付出很少的额外努力收集和分析所需信息,为潜在采用者提供有关采用行为干预措施的成本信息。在使用试验数据时的一个关键挑战是将实施成本(采用者将承担的成本)与研究成本分开。基于对 3 项行为干预随机临床试验的经验,本文解释了如何构建成本核算问题,包括如何考虑与对照组相关的成本,以及描述了收集个人成本数据的方法:支持所需专门功能的技术平台的成本核算规范,如何设置时间记录以收集有关员工实施工作时间的数据,以及获取设备、间接费用和经济激励成本数据的问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f4/7772275/3267c509cdb9/nihms-1640567-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f4/7772275/3267c509cdb9/nihms-1640567-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f4/7772275/3267c509cdb9/nihms-1640567-f0001.jpg

相似文献

1
Using Clinical Trial Data to Estimate the Costs of Behavioral Interventions for Potential Adopters: A Guide for Trialists.利用临床试验数据估算潜在采用者行为干预措施的成本:试验研究者指南。
Med Decis Making. 2021 Jan;41(1):9-20. doi: 10.1177/0272989X20973160. Epub 2020 Nov 20.
2
Costing behavioral interventions: a practical guide to enhance translation.行为干预成本核算:促进转化的实用指南
Ann Behav Med. 2009 Apr;37(2):218-27. doi: 10.1007/s12160-009-9088-5. Epub 2009 Mar 17.
3
Cost of behavioral interventions utilizing electronic drug monitoring for antiretroviral therapy adherence.利用电子药物监测进行抗逆转录病毒治疗依从性的行为干预的成本。
J Acquir Immune Defic Syndr. 2013 May 1;63(1):e1-8. doi: 10.1097/QAI.0b013e318285d951.
4
Methods for economic evaluation alongside a multicentre trial in developing countries: a case study from the WHO Antenatal Care Randomised Controlled Trial.发展中国家多中心试验中的经济评估方法:来自世界卫生组织产前护理随机对照试验的案例研究
Paediatr Perinat Epidemiol. 1998 Oct;12 Suppl 2:75-97. doi: 10.1046/j.1365-3016.1998.00008.x.
5
Financial incentives to improve adherence to antipsychotic maintenance medication in non-adherent patients: a cluster randomised controlled trial.针对未坚持服用抗精神病维持药物的患者,采用经济激励措施提高其依从性:一项整群随机对照试验。
Health Technol Assess. 2016 Sep;20(70):1-122. doi: 10.3310/hta20700.
6
Cost-Effectiveness and Affordability of Interventions, Policies, and Platforms for the Prevention and Treatment of Mental, Neurological, and Substance Use Disorders预防和治疗精神、神经及物质使用障碍的干预措施、政策和平台的成本效益及可负担性
7
The design and conduct of Keep It Off: An online randomized trial of financial incentives for weight-loss maintenance.“保持体重:一项关于减肥维持经济激励措施的在线随机试验”的设计与实施。
Clin Trials. 2017 Feb;14(1):29-36. doi: 10.1177/1740774516669679. Epub 2016 Sep 23.
8
Efficient Research Design: Using Value-of-Information Analysis to Estimate the Optimal Mix of Top-down and Bottom-up Costing Approaches in an Economic Evaluation alongside a Clinical Trial.高效研究设计:在一项与临床试验同步进行的经济评估中,运用信息价值分析来估计自上而下和自下而上成本核算方法的最佳组合。
Med Decis Making. 2016 Apr;36(3):335-48. doi: 10.1177/0272989X15622186. Epub 2016 Jan 13.
9
Youth social behaviour and network therapy (Y-SBNT): adaptation of a family and social network intervention for young people who misuse alcohol and drugs - a randomised controlled feasibility trial.青少年社会行为与网络疗法(Y-SBNT):针对酒精和药物滥用青少年的家庭与社会网络干预措施的改编——一项随机对照可行性试验。
Health Technol Assess. 2017 Mar;21(15):1-260. doi: 10.3310/hta21150.
10
Economic analysis of a tailored behavioral intervention to improve blood pressure control for primary care patients.针对初级保健患者改善血压控制的定制行为干预的经济分析。
Am Heart J. 2010 Aug;160(2):257-63. doi: 10.1016/j.ahj.2010.05.024.

引用本文的文献

1
Cost-Effectiveness of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients With Elevated Risk for Cardiovascular Disease.游戏化、经济激励或两者结合对心血管疾病风险升高患者增加身体活动的成本效益分析。
Circ Cardiovasc Qual Outcomes. 2025 Jul;18(7):e011839. doi: 10.1161/CIRCOUTCOMES.124.011839. Epub 2025 Jun 17.
2
Remote Patient-Reported Outcomes and Activity Monitoring to Improve Patient-Clinician Communication Regarding Symptoms and Functional Status: A Randomized Controlled Trial.远程患者报告结局和活动监测以改善症状和功能状态的医患沟通:一项随机对照试验。
JCO Oncol Pract. 2023 Dec;19(12):1143-1151. doi: 10.1200/OP.23.00048. Epub 2023 Oct 10.
3

本文引用的文献

1
Incentives for smoking cessation.戒烟的激励措施。
Cochrane Database Syst Rev. 2019 Jul 17;7(7):CD004307. doi: 10.1002/14651858.CD004307.pub6.
2
The Habit Formation trial of behavioral economic interventions to improve statin use and reduce the risk of cardiovascular disease: Rationale, design and methodologies.行为经济学干预措施养成习惯试验,以提高他汀类药物的使用并降低心血管疾病风险:原理、设计和方法学。
Clin Trials. 2019 Aug;16(4):399-409. doi: 10.1177/1740774519846852. Epub 2019 May 31.
3
Rationale and Design of EMPOWER, a Pragmatic Randomized Trial of Automated Hovering in Patients With Congestive Heart Failure.
Food Is Medicine: A Presidential Advisory From the American Heart Association.
食物是良药:美国心脏协会的总统顾问报告
Circulation. 2023 Oct 31;148(18):1417-1439. doi: 10.1161/CIR.0000000000001182. Epub 2023 Sep 28.
4
A randomized, controlled, prehabilitation intervention to maximize early recovery (PRIMER) in liver transplantation.随机、对照、预康复干预以实现肝移植的早期康复(PRIMER)。
Liver Transpl. 2024 Jan 1;30(1):10-19. doi: 10.1097/LVT.0000000000000198. Epub 2023 Jun 29.
5
A randomized controlled trial of gamification, financial incentives, or both to increase physical activity among patients with elevated risk for cardiovascular disease: rationale and design of the be active study.一项针对提高心血管疾病高危患者身体活动的游戏化、经济激励或两者结合的随机对照试验:积极研究的原理和设计。
Am Heart J. 2023 Jun;260:82-89. doi: 10.1016/j.ahj.2023.02.014. Epub 2023 Mar 2.
6
Patient and clinician nudges to improve symptom management in advanced cancer using patient-generated health data: study protocol for the PROStep randomised controlled trial.利用患者生成的健康数据改善晚期癌症患者症状管理的患者和临床医生推动因素:PROStep 随机对照试验研究方案。
BMJ Open. 2022 May 12;12(5):e054675. doi: 10.1136/bmjopen-2021-054675.
7
Effect of Financial Incentives for Process, Outcomes, or Both on Cholesterol Level Change: A Randomized Clinical Trial.经济激励对过程、结果或两者同时对胆固醇水平变化的影响:一项随机临床试验。
JAMA Netw Open. 2021 Oct 1;4(10):e2121908. doi: 10.1001/jamanetworkopen.2021.21908.
8
Cost-Effectiveness of Four Financial Incentive Programs for Smoking Cessation.四种戒烟财政激励方案的成本效益分析。
Ann Am Thorac Soc. 2021 Dec;18(12):1997-2006. doi: 10.1513/AnnalsATS.202012-1473OC.
充血性心力衰竭患者自动悬停实用随机试验EMPOWER的原理与设计
Circ Cardiovasc Qual Outcomes. 2019 Apr;12(4):e005126. doi: 10.1161/CIRCOUTCOMES.118.005126.
4
The Uncertain Effect of Financial Incentives to Improve Health Behaviors.经济激励对改善健康行为的不确定影响。
JAMA. 2019 Apr 16;321(15):1451-1452. doi: 10.1001/jama.2019.2560.
5
Interventions to improve adherence to lipid-lowering medication.提高降脂药物依从性的干预措施。
Cochrane Database Syst Rev. 2016 Dec 21;12(12):CD004371. doi: 10.1002/14651858.CD004371.pub4.
6
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.《健康与医疗领域成本效益分析的实施、方法学实践和报告推荐:第二版》。
JAMA. 2016 Sep 13;316(10):1093-103. doi: 10.1001/jama.2016.12195.
7
Costs for a health coaching intervention for chronic care management.用于慢性病管理的健康指导干预措施的成本。
Am J Manag Care. 2016 Apr 1;22(4):e141-6.
8
Real-time adherence monitoring for HIV antiretroviral therapy.实时抗逆转录病毒疗法的依从性监测。
AIDS Behav. 2010 Dec;14(6):1340-6. doi: 10.1007/s10461-010-9799-4.